StonvexLoading…
StonvexStonvexStonvexCore line items from HLNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $565.43M | $366.84M | $175.96M | $712.96M |
Operating Income | $333.08M | $213.03M | $95.45M | $362.28M |
Net Income | $183.01M | $124.63M | $53.74M | $217.42M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $2.17B | $1.98B | $1.80B | $1.69B |
Total Liabilities | $844.76M | $822.27M | $806.99M | $766.46M |
Cash & Equivalents | $347.98M | $334.35M | $322.14M | $283.60M |
Free Cash Flow OCF − CapEx | $317.85M | $245.40M | $127.59M | $288.66M |
Shares Outstanding | Not available | Not available | Not available | Not available |